Your browser doesn't support javascript.
loading
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies.
Manry, Jeremy; Bastard, Paul; Gervais, Adrian; Le Voyer, Tom; Rosain, Jérémie; Philippot, Quentin; Michailidis, Eleftherios; Hoffmann, Hans-Heinrich; Eto, Shohei; Garcia-Prat, Marina; Bizien, Lucy; Parra-Martínez, Alba; Yang, Rui; Haljasmägi, Liis; Migaud, Mélanie; Särekannu, Karita; Maslovskaja, Julia; de Prost, Nicolas; Tandjaoui-Lambiotte, Yacine; Luyt, Charles-Edouard; Amador-Borrero, Blanca; Gaudet, Alexandre; Poissy, Julien; Morel, Pascal; Richard, Pascale; Cognasse, Fabrice; Troya, Jesus; Trouillet-Assant, Sophie; Belot, Alexandre; Saker, Kahina; Garçon, Pierre; Rivière, Jacques G; Lagier, Jean-Christophe; Gentile, Stéphanie; Rosen, Lindsey; Shaw, Elana; Morio, Tomohiro; Tanaka, Junko; Dalmau, David; Tharaux, Pierre-Louis; Sene, Damien; Stepanian, Alain; Mégarbane, Bruno; Triantafyllia, Vasiliki; Fekkar, Arnaud; Heath, James; Franco, Jose; Anaya, Juan-Manuel; Solé-Violán, Jordi; Imberti, Luisa.
Afiliación
  • Manry J; INSERM U1163.
  • Bastard P; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163.
  • Gervais A; INSERM U1163.
  • Le Voyer T; INSERM U1163.
  • Rosain J; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM.
  • Philippot Q; INSERM U1163.
  • Michailidis E; The Rockefeller University, Laboratory of Virology and Infectious Disease.
  • Hoffmann HH; Laboratory of Virology and Infectious Disease, Rockefeller University.
  • Eto S; Department of Pediatrics, Graduate School of Biomedical and Health Sciences, Hiroshima University.
  • Garcia-Prat M; Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute.
  • Bizien L; INSERM U1163.
  • Parra-Martínez A; Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute.
  • Yang R; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University.
  • Haljasmägi L; University of Tartu.
  • Migaud M; INSERM U1163.
  • Särekannu K; Institute of Biomedicine and Translational Medicine, University of Tartu.
  • Maslovskaja J; Institute of Biomedicine and Translational Medicine, University of Tartu.
  • de Prost N; Hôpitaux Universitaires Henri Mondor.
  • Tandjaoui-Lambiotte Y; Avicenne Hospital, AP-HP, Bobigny, INSERM U1272, Hypoxia and Lung.
  • Luyt CE; Hôpital Pitié-Salpêtrière, Service de Médecine Intensive Réanimation, Institut de Cardiologie.
  • Amador-Borrero B; Internal Medicine Department, Lariboisière Hospital AP-HP, Paris University.
  • Gaudet A; University of Lille, U1019-UMR9017, Center for Infection and Immunity of Lille.
  • Poissy J; University of Lille, U1019-UMR9017, Center for Infection and Immunity of Lille.
  • Morel P; Etablissement Français Du Sang.
  • Richard P; Etablissement Français Du Sang.
  • Cognasse F; Etablissement Français du Sang, Auvergne-Rhône-Alpes.
  • Troya J; Department of Internal Medicine, Infanta Leonor University Hospital.
  • Trouillet-Assant S; Hospices Civils de Lyon.
  • Belot A; Hospices Civils de Lyon.
  • Saker K; Hospices Civils de Lyon.
  • Garçon P; Intensive Care Unit, Grand Hôpital de l'Est Francilien Site de Marne-La-Vallée.
  • Rivière JG; Hospital Universitari Vall d'Hebron.
  • Lagier JC; Méditerranée Infection Foundation.
  • Gentile S; Service d'Evaluation Médicale, Hôpitaux Universitaires de Marseille APHM.
  • Rosen L; National Institutes of Health.
  • Shaw E; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health.
  • Morio T; Tokyo Medical and Dental University.
  • Tanaka J; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima Universit.
  • Dalmau D; Hospital Universitari MútuaTerrassa; Fundació Docència i Recerca MutuaTerrassa, Terrasa; Universitat de Barcelona.
  • Tharaux PL; Institut National de la Santé et de la Recherche Médicale (INSERM).
  • Sene D; Internal Medicine Department, Lariboisière Hospital AP-HP, Paris University.
  • Stepanian A; Service d'Hématologie Biologique, Hôpital Lariboisière, AP-HP and EA3518, Institut Universitaire d'Hématologie-Hôpital Saint Louis, Université Paris.
  • Mégarbane B; Réanimation Médicale et Toxicologique, Hôpital Lariboisière (AP-HP), Université Paris-Diderot, INSERM Unité Mixte de Recherche Scientifique (UMRS) 1144.
  • Triantafyllia V; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery, and Translational Research, Biomedical Research Foundation of the Academy of Athens.
  • Fekkar A; INSERM U1163.
  • Heath J; Institute for Systems Biology.
  • Franco J; University of Antioquia.
  • Anaya JM; Universidad del Rosario.
  • Solé-Violán J; Intensive Care Medicine, University Hospital of Gran Canaria Dr. Negrín, Canarian Health System.
  • Imberti L; CREA Laboratory (AIL Center for Hemato-Oncologic Research), Diagnostic Department, ASST Spedali Civili di Brescia.
Res Sq ; 2022 Jan 14.
Article en En | MEDLINE | ID: mdl-35043109
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Res Sq Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Res Sq Año: 2022 Tipo del documento: Article